VRTX logo

VRTX
Vertex Pharmaceuticals, Inc.

12,672
Mkt Cap
$115.03B
Volume
692,988.00
52W High
$519.68
52W Low
$362.50
PE Ratio
31.95
VRTX Fundamentals
Price
$453.36
Prev Close
$453.74
Open
$451.75
50D MA
$436.81
Beta
0.54
Avg. Volume
1.46M
EPS (Annual)
-$2.08
P/B
6.65
Rev/Employee
$1.8M
Loading...
Loading...
News
all
press releases
Best Biotech Stocks To Follow Now - January 1st
Vertex Pharmaceuticals, Danaher, Abivax, Moderna, and United Therapeutics are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of...
MarketBeat·14h ago
News Placeholder
More News
News Placeholder
VIRGINIA RETIREMENT SYSTEMS ET Al Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX
VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the third quarter, according to its most recent filing with the...
MarketBeat·20h ago
News Placeholder
25,734 Shares in Vertex Pharmaceuticals Incorporated $VRTX Bought by Generate Investment Management Ltd
Generate Investment Management Ltd bought a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 3rd quarter, according to its most recent filing with the...
MarketBeat·2d ago
News Placeholder
Ethic Inc. Has $5.47 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX
Ethic Inc. boosted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 21.5% during the third quarter, according to the company in its most recent filing with...
MarketBeat·2d ago
News Placeholder
Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $453.74, marking a -1.31% move from the previous day.
Zacks·2d ago
News Placeholder
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·3d ago
News Placeholder
Best Biotech Stocks To Consider - December 29th
Danaher, Vertex Pharmaceuticals, and Abivax are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that...
MarketBeat·4d ago
News Placeholder
Leerink Partners Boosts Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $525.00
Leerink Partners lifted their price objective on Vertex Pharmaceuticals from $456.00 to $525.00 and gave the stock an "outperform" rating in a report on Monday...
MarketBeat·4d ago
News Placeholder
Best Biotech Stocks To Follow Now - December 28th
Danaher, Moderna, Vertex Pharmaceuticals, Cidara Therapeutics, United Therapeutics, Medpace, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...
MarketBeat·5d ago
News Placeholder
Burney Co. Reduces Position in Vertex Pharmaceuticals Incorporated $VRTX
Burney Co. cut its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 83.1% during the third quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·5d ago
<
1
2
...
>

Latest VRTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.